Patients with treated indolent lymphomas immunized with BNT162b2 have reduced anti-spike neutralizing IgG to SARS-CoV-2 variants, but preserved antigen-specific T cell responses.

The difference in median MFI between TN‐ and BTKi‐treated patients was also highly significant ( p = .0008; values above).

also in 132,142 other papers

There was comparable neutralization for both cell lines within cohorts, with a nonsignificant trend toward reduced neutralization for the delta variant (Table S2 ).

also in 5,406 other papers